Jacques-Pierre Moreau

Author

Also Known As

J P Moreau, JACQUES‐PIERRE MOREAU, Jacques-Pierre Moreau

Publications

407

Citations

H-Index

Concepts

All Affiliations

Jacques-Pierre Moreau is an author at Institut Gustave Roussy specializing in medicine, pharmacology, and oncology.

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	287
2	Cell Biology	2	2	144
3	Immunology	2	2	102
4	Health Sciences	1	1	16
5	Endocrinology	1	1	86

Jacques-Pierre Moreau

Publications

328

Citations

H-Index

Page 1

	Year	Citations
In vitro and in vivo inhibition of human small cell lung carcinoma (NCl-H69) growth by a somatostatin analogue John E. Taylor, Arthur E. Bogdén, Jacques-Pierre Moreau, Biochemical and Biophysical Research Communications Vivo InhibitionOncogenic AgentMedicinePharmacologyCancer Growth	1988	128
Suppression of Rat and Human Growth Hormone and Prolactin Secretion by a Novel Somatostatin/Dopaminergic Chimeric Ligand Song-Guang Ren, Sun H. Kim, John E. Taylor, The Journal of Clinical Endocrinology & Metabolism Pituitary Gh SecretionHuman GrowthImmunologyPharmacotherapyGastrointestinal Peptide Hormone	2003	86
Amelioration of Chemotherapy‐Induced Toxicity by Cotreatment with AcSDKP, a Tetrapeptide Inhibitor of Hematopoietic Stem Cell Proliferation Arthur E. Bogdén, Patrice Carde, E. Deschamps de Paillette, Annals of the New York Academy of Sciences Chemotherapy‐induced ToxicityOncologyTetrapeptide InhibitorPharmacologyPharmacotherapy	1991	57
Treatment of R-3327 prostate tumors with a somatostatin analogue (somatuline) as adjuvant therapy following surgical castration. Arthur E. Bogdén, John E. Taylor, Jacques-Pierre Moreau, PubMed	1990	41
Goralatide (AcSDKP), a negative growth regulator, protects the stem cell compartment during chemotherapy, enhancing the myelopoietic response to GM-CSF Arthur E. Bogdén, Jacques-Pierre Moreau, Christina Gamba‐Vitalo, International Journal of Cancer ImmunologyImmunotherapyMyelopoietic ResponseMyeloid NeoplasiaHematological Malignancy	1998	16

Page 1